Amgen's R&D expenses amounted to approximately 4.8 billion U.S. dollars in 2024. This statistic shows the expenditure on research and development of biotech company Amgen from 2004 to 2024. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Amgen" in one document: edited and divided into chapters, including detailed references.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron
CEO, MindShare Germany
Overview
Financials
Products and regions
Competitors
Research and development
Further related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
